Need professional-grade analysis? Visit stockanalysis.com
$4.32B
N/A
N/A
N/A
Guangdong Hybribio Biotech Co Ltd (300639) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY6.27, down 5.43% from the previous close.
Over the past year, 300639 has traded between a low of CNY4.96 and a high of CNY8.81. The stock has gained 22.0% over this period. It is currently 28.8% below its 52-week high.
Guangdong Hybribio Biotech Co Ltd has a market capitalization of $4.32B.
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company was founded in 2003 and is based in Chaozhou, China.
Side-by-side comparison against top Healthcare peers.